Vaccine News and Research

Latest Vaccine News and Research

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

CDC expected to revise H1N1 mortality figures

The New York Times: "About 4,000 Americans - rather than about 1,200 - have died of swine flu since the disease emerged in April, according to new figures being calculated by [CDC] epidemiologists" - an estimate that combines the number of "deaths from laboratory-confirmed cases of the flu and deaths that appear to be brought on by flu, even though the patient may have ultimately died of bacterial pneumonia, other infections or organ failure."

12 Nov 2009

IACC to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research

Autism Speaks is encouraged by yesterday's decision of the Interagency Autism Coordinating Committee (IACC) to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research. The new language, approved unanimously, calls for studies to determine if there are sub-populations that are more susceptible to environmental exposures such as immune challenges related to naturally occurring infections, vaccines or underlying immune problems.

12 Nov 2009

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.

12 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function.

12 Nov 2009

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

CSL Biotherapies, a subsidiary of CSL Limited, one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older.

12 Nov 2009

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Emergency Management & Safety Solutions (EMS Solutions), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help companies better prepare for and prevent transmission of this year's H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and approximately 6,500 people have died -- including over 1,500 in North America, according to the European Center for Disease Prevention and Control.

12 Nov 2009

Drug companies collaborate with nonprofit organizations to fight "neglected" diseases in the developing world

Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That's the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

12 Nov 2009

Adamis Labs secures orders from three major wholesale distributers in U.S.

Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that its wholly owned subsidiary, Adamis Labs has now secured distribution contracts and initial stocking orders from the three major wholesalers of prescription drugs in the U.S.

11 Nov 2009

UK research funders announce support for a series of H1N1 2009 research projects

Leading UK research funders today announce -7.5 million of funding for a series of projects aimed at understanding the development and spread of pandemic influenza H1N1 2009 - or 'swine flu'. The research will look at every aspect of the virus, on pig farms, in pig and human populations, and in hospital intensive care units.

11 Nov 2009

FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak

Dr. Margaret Hamburg, Commissioner of Food and Drugs, today sent a letter to America's doctors, thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on the safety of the 2009 H1N1 vaccines.

11 Nov 2009

Lower socioeconomic status linked with inability to fight H1N1

People who did not earn a high school diploma could be more likely to get H1N1 and the vaccine might be less effective in them compared to those who earned a diploma, new research shows.

11 Nov 2009

Emory researchers present public health research findings at American Public Health Association meeting

Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

Negative and positive emotions have a direct impact on pain, says new study

Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine. According to a new Universit- de Montr-al study, published in the latest edition of the Proceedings of the National Academy of Sciences (PNAS), negative and positive emotions have a direct impact on pain.

11 Nov 2009

Data on Alexion Pharmaceuticals' Soliris to be presented at the ASH meeting

Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.

11 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

LA BioMed to participate in a national study of the effectiveness of testosterone

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

CDC expected to revise estimated number of U.S. H1N1 deaths

CDC expected to revise H1N1 mortality figures

IACC to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Drug companies collaborate with nonprofit organizations to fight "neglected" diseases in the developing world

Adamis Labs secures orders from three major wholesale distributers in U.S.

UK research funders announce support for a series of H1N1 2009 research projects

FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak

Lower socioeconomic status linked with inability to fight H1N1

Emory researchers present public health research findings at American Public Health Association meeting

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Negative and positive emotions have a direct impact on pain, says new study

Data on Alexion Pharmaceuticals' Soliris to be presented at the ASH meeting

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in